Published in J Neurosci Methods on June 05, 2012
SaBer DBS: a fully programmable, rechargeable, bilateral, charge-balanced preclinical microstimulator for long-term neural stimulation. J Neurosci Methods (2013) 0.89
An inexpensive, charge-balanced rodent deep brain stimulation device: a step-by-step guide to its procurement and construction. J Neurosci Methods (2013) 0.78
A long-lasting wireless stimulator for small mammals. Front Neuroeng (2013) 0.77
An implantable device for neuropsychiatric rehabilitation by chronic deep brain stimulation in freely moving rats. Neuroreport (2017) 0.75
A Low Power Micro Deep Brain Stimulation Device for Murine Preclinical Research. IEEE J Transl Eng Health Med (2013) 0.75
A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice. J Physiol (2015) 0.75
Deep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving Animals. Parkinsons Dis (2017) 0.75
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry (2005) 1.80
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder. J Clin Psychiatry (2004) 1.57
Melanocortin receptor 4 deficiency affects body weight regulation, grooming behavior, and substrate preference in the rat. Obesity (Silver Spring) (2011) 1.50
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder. J Clin Psychopharmacol (2003) 1.36
Autonomic and neuroendocrine responses to a psychosocial stressor in adults with autistic spectrum disorder. J Autism Dev Disord (2006) 1.26
The neurobiology of repetitive behavior: …and men. Neurosci Biobehav Rev (2010) 1.23
Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry (2007) 1.22
Sciatic nerve regeneration in mice and rats: recovery of sensory innervation is followed by a slowly retreating neuropathic pain-like syndrome. Brain Res (2004) 1.16
Thinner prefrontal cortex in veterans with posttraumatic stress disorder. Neuroimage (2008) 1.12
Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry (2004) 1.12
Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS One (2013) 1.12
Contactins in the neurobiology of autism. Eur J Pharmacol (2013) 1.11
The neurobiology of repetitive behavior: of mice…. Neurosci Biobehav Rev (2010) 1.09
Difference in susceptibility to activity-based anorexia in two inbred strains of mice. Eur Neuropsychopharmacol (2006) 1.07
Effects of genetic background and environmental novelty on wheel running as a rewarding behaviour in mice. Behav Brain Res (2006) 1.06
Single-cell and population coding of expected reward probability in the orbitofrontal cortex of the rat. J Neurosci (2009) 1.05
Glutamate and anxiety. Eur Neuropsychopharmacol (2004) 1.05
The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry (2004) 1.04
Neural correlates of associative learning and memory in veterans with posttraumatic stress disorder. J Psychiatr Res (2007) 1.04
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry (2004) 1.03
Daily rhythms in metabolic liver enzymes and plasma glucose require a balance in the autonomic output to the liver. Endocrinology (2007) 1.03
Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry (2002) 1.02
Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Res (2004) 0.98
Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review. Int Clin Psychopharmacol (2006) 0.98
Current status and future prospects for epigenetic psychopharmacology. Epigenetics (2012) 0.96
Leptin treatment in activity-based anorexia. Biol Psychiatry (2005) 0.94
Deep brain stimulation reveals a dissociation of consummatory and motivated behaviour in the medial and lateral nucleus accumbens shell of the rat. PLoS One (2012) 0.94
Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure. Psychopathology (2004) 0.93
Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology (2012) 0.92
Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder. Int Clin Psychopharmacol (2003) 0.92
Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. Biol Psychiatry (2005) 0.91
Hyperactivity in anorexia nervosa: warming up not just burning-off calories. PLoS One (2012) 0.90
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Inverse agonism gains weight. Trends Pharmacol Sci (2003) 0.90
Behavioral, physiological, and molecular differences in response to dietary restriction in three inbred mouse strains. Am J Physiol Endocrinol Metab (2006) 0.90
Precuneal activity during encoding in veterans with posttraumatic stress disorder. Prog Brain Res (2008) 0.90
Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. J Clin Psychiatry (2007) 0.88
Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology (Berl) (2003) 0.88
Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol (2006) 0.87
Reduced sensitivity in the recognition of anger and disgust in social anxiety disorder. Cogn Neuropsychiatry (2006) 0.87
Assessment of DSM-IV personality disorders in obsessive-compulsive disorder: comparison of clinical diagnosis, self-report questionnaire, and semi-structured interview. J Pers Disord (2003) 0.87
Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats. Biol Psychiatry (2006) 0.87
Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorder. J Affect Disord (2004) 0.87
Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. Psychiatry Res (2005) 0.87
Olanzapine reduces physical activity in rats exposed to activity-based anorexia: possible implications for treatment of anorexia nervosa? Biol Psychiatry (2005) 0.87
Sensory gating and sensorimotor gating in medication-free obsessive-compulsive disorder patients. Int Clin Psychopharmacol (2010) 0.87
Functional analysis of the Ala67Thr polymorphism in agouti related protein associated with anorexia nervosa and leanness. Biochem Pharmacol (2005) 0.86
Attention and cognition in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci (2007) 0.86
Melanocortin system and eating disorders. Ann N Y Acad Sci (2003) 0.86
Fibroblast growth factors in neurodevelopment and psychopathology. Neuroscientist (2013) 0.86
Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophr Bull (2010) 0.85
Sex-dependent novelty response in neurexin-1α mutant mice. PLoS One (2012) 0.84
Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care. J Psychopharmacol (2003) 0.84
A meta-analysis of circulating BDNF concentrations in anorexia nervosa. World J Biol Psychiatry (2011) 0.83
AgRP(83-132) and SHU9119 differently affect activity-based anorexia. Eur Neuropsychopharmacol (2005) 0.83
Sexual pleasure in women with obsessive-compulsive disorder? J Affect Disord (2006) 0.82
Alterations in blood glucose and plasma glucagon concentrations during deep brain stimulation in the shell region of the nucleus accumbens in rats. Front Neurosci (2013) 0.82
Spatial working memory in obsessive-compulsive disorder improves with clinical response: A functional MRI study. Eur Neuropsychopharmacol (2006) 0.82
Behavioural genetics in mood and anxiety: a next step in finding novel pharmacological targets. Eur J Pharmacol (2008) 0.82
Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. J Affect Disord (2010) 0.81
A grandparent-influenced locus for alcohol preference on mouse chromosome 2. Pharmacogenet Genomics (2009) 0.81
Alterations in serotonin signalling are involved in the hyperactivity of Pitx3-deficient mice. Eur J Neurosci (2008) 0.81
Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice. Psychopharmacology (Berl) (2002) 0.81
Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients. J Clin Psychiatry (2009) 0.81
Evaluation of temperature rise and bonding strength in cements used for permanent head attachments in rats and mice. Lab Anim (2010) 0.81
Influence of transgenic corticotropin-releasing factor (CRF) over-expression on social recognition memory in mice. Behav Brain Res (2010) 0.81
Obstructive sleep apnea in combat-related posttraumatic stress disorder: a controlled polysomnography study. Eur J Psychotraumatol (2011) 0.81
Behavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats. J Psychopharmacol (2010) 0.80
Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice. Eur J Pharmacol (2003) 0.80
Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial. Int J Neuropsychopharmacol (2003) 0.80
alpha-MSH enhances activity-based anorexia. Peptides (2005) 0.80
Gene expression profiling in C57BL/6J and A/J mouse inbred strains reveals gene networks specific for brain regions independent of genetic background. BMC Genomics (2010) 0.80
Neuroendocrine and immune responses to a cognitive stress challenge in veterans with and without PTSD. Eur J Psychotraumatol (2012) 0.80
The parent-of-origin of the extra X chromosome may differentially affect psychopathology in Klinefelter syndrome. Biol Psychiatry (2010) 0.80
The Val66Met polymorphism of the BDNF gene in anorexia nervosa: new data and a meta-analysis. World J Biol Psychiatry (2011) 0.80
To eat or not to eat; regulation by the melanocortin system. Physiol Behav (2006) 0.80
Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. J Affect Disord (2006) 0.80
Mandometer treatment not superior to treatment as usual for anorexia nervosa. Int J Eat Disord (2011) 0.80
Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study. Int Clin Psychopharmacol (2010) 0.79
Voluntary access to a warm plate reduces hyperactivity in activity-based anorexia. Physiol Behav (2005) 0.79
Predictors of recovery of ovarian function during weight gain in anorexia nervosa. Fertil Steril (2007) 0.79
Signaling pathways involved in Ca2+- and Pb2+-induced vesicular catecholamine release from rat PC12 cells. Brain Res (2002) 0.79
Neuropsychological performance is related to current social and occupational functioning in veterans with posttraumatic stress disorder. Depress Anxiety (2009) 0.79
The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice. Eur J Pharmacol (2002) 0.79
Compulsivity in mouse strains homologous with chromosomes 7p and 15q linked to obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 0.79
Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study. J Clin Psychiatry (2005) 0.79
Translational research into sexual disorders: pharmacology and genomics. Eur J Pharmacol (2008) 0.79
Nurse evaluation of hyperactivity in anorexia nervosa: a comparative study. Eur Eat Disord Rev (2007) 0.78
Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology (2009) 0.78
Longitudinal changes in the physical activity of adolescents with anorexia nervosa and their influence on body composition and leptin serum levels after recovery. PLoS One (2013) 0.78
Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats. Int J Neuropsychopharmacol (2006) 0.78
Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade. Psychopharmacology (Berl) (2003) 0.78
Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo. J Psychiatr Res (2008) 0.78
Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740. Int Clin Psychopharmacol (2005) 0.78
Melanocortin MC(4) receptor-mediated feeding and grooming in rodents. Eur J Pharmacol (2013) 0.77
The influence of amphetamine on language activation: an fMRI study. Psychopharmacology (Berl) (2005) 0.77
Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine. Psychopharmacology (Berl) (2004) 0.77